A phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of bacillus Calmette-Guérin refractory nonmuscle invasive bladder cancer

Journal of Urology

Volumn 186, Issue 2, 2011, Pages 448-451

  McKiernan, James M ^a   Barlow, Lamont J ^a   Laudano, Melissa A ^a   Mann, Mark J ^a   Petrylak, Daniel P ^a   Benson, Mitchell C ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

administration; intravesical; nanotechnology; paclitaxel; urinary bladder neoplasms

Indexed keywords

ALBUMIN; BCG VACCINE; DOCETAXEL; INTERFERON; MITOMYCIN C; NANOPARTICLE; PACLITAXEL;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COMORBIDITY; CYSTOSCOPY; DYSURIA; FEMALE; HEMATURIA; HIGH RISK PATIENT; HUMAN; MALE; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE; URETHRAL CATHETERIZATION; URINARY FREQUENCY; URINE RETENTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; ALBUMINS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; NANOPARTICLES; NEOPLASM INVASIVENESS; PACLITAXEL; TREATMENT FAILURE; URINARY BLADDER NEOPLASMS;

EID: 79960194055     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.129     Document Type: Article

References (17)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71
2. S.B. Malkowicz Management of superficial bladder cancer P.C. Walsh, A.B. Retik, E.D. Vaughan, 8th ed. Campbell's Urology vol 4 2002 WB Saunders Philadelphia 2785
3. E.D. Crawford Intravesical therapy for superficial cancer: need for more options J Clin Oncol 20 2002 3185
4. A. Morales Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer J Urol 132 1984 457
5. D.L. Lamm, B.A. Blumenstein, and J.D. Crissman Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study J Urol 163 2000 1124
6. H.W. Herr, D.D. Wartinger, and W.R. Fair Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup J Urol 147 1992 1020
7. V. Pansadoro, P. Emiliozzi, and L. Defidio Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results J Urol 154 1995 2054
8. J.C. Kim, and G.D. Steinberg Medical management of patients with refractory carcinoma in situ of the bladder Drugs Aging 18 2001 335
9. R. de Wit, W.H. Kruit, and G. Stoter Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients Br J Cancer 78 1998 1342
10. S. Chan, K. Friedrichs, and D. Noel Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer J Clin Oncol 17 1999 2341
11. I.F. Tannock, R. de Wit, and W.R. Berry Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 2004 1502
12. J.M. McKiernan, P. Masson, and A.M. Murphy Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy J Clin Oncol 24 2006 3075
13. A. Sparreboom, C.D. Scripture, and V. Trieu Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol) Clin Cancer Res 11 2005 4136
14. W.J. Gradishar, S. Tjulandin, and N. Davidson Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J Clin Oncol 23 2005 7794
15. N.M. Heney, S. Ahmed, and M.J. Flanagan Superficial bladder cancer: progression and recurrence J Urol 130 1983 1083
16. D.G. Skinner, E.D. Crawford, and J.J. Kaufman Complications of radical cystectomy for carcinoma of the bladder J Urol 123 1980 640
17. E.R. Gardner, W.L. Dahut, and C.D. Scripture Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel Clin Cancer Res 14 2008 4200